Therapeutic Drug Monitoring Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Therapeutic Drug Monitoring Pipeline Market Report Overview

Therapeutic drug monitoring tests include reagents and test kits intended to measure different types of therapeutic drugs from samples ranging from serum/blood, urine, hair and sweat.

The therapeutic drug monitoring pipeline market research report provides comprehensive information about the Therapeutic drug monitoring pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Key Segments ·       Immunosuppressant Therapeutic Drug Monitoring

·       Central Nervous Systems Therapeutic Drug Monitoring

·       Antibiotic/Antivirus Therapeutic Drug Monitoring

·       Cardiovascular Therapeutic Drug Monitoring

Key Territories ·       United States

·       Europe

·       India

·       United Kingdom

·       Others

Key Regulatory Paths ·       510(k)

·       CE-IVD

·       ICAC

·       MDITAC

·       Others

Leading Companies ·       20/20 GeneSystems Inc

·       BG Medicine Inc

·       Eurobio Scientific SA

·       Horiba Ltd

·       Others

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Therapeutic drug monitoring Pipeline Market by Segments

The key segments in the therapeutic drug monitoring market are immunosuppressant therapeutic drug monitoring, central nervous systems therapeutic drug monitoring, antibiotic/antivirus therapeutic drug monitoring, and cardiovascular therapeutic drug monitoring. As of July 2023, the immunosuppressant therapeutic drug monitoring segment had the highest number of pipeline products.

Therapeutic Drug Monitoring Pipeline Market Analysis by Segments, 2023 (%)

Therapeutic Drug Monitoring Pipeline Market Analysis by Segments, 2023 (%)

For more segment insights into the therapeutic drug monitoring pipeline market, download a free report sample

Therapeutic Drug Monitoring Pipeline Market Segmentation by Territories

Some of the key territories in the therapeutic drug monitoring market are the US, the UK, Europe, India, and Australia among others. As of July 2023, the US had the highest number of pipeline products.

Therapeutic Drug Monitoring Pipeline Market Analysis by Territories, 2023 (%)

Therapeutic Drug Monitoring Pipeline Market Analysis by Territories, 2023 (%)

For more territory insights into the therapeutic drug monitoring pipeline market, download a free report sample

Therapeutic Drug Monitoring Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths in the therapeutic drug monitoring pipeline market are 510(k), CE-IVD, ICAC, MDITAC, and Ninsho, among others. As of July 2023, 510(k) was the most followed pathway for pipeline products.

Therapeutic Drug Monitoring Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Therapeutic Drug Monitoring Pipeline Market Analysis by Regulatory Paths, 2023 (%)

For more regulatory path insights into the therapeutic drug monitoring pipeline market, download a free report sample

Therapeutic Drug Monitoring Pipeline Market – Competitive Landscape

Some of the key companies in the therapeutic drug monitoring pipeline market are 20/20 GeneSystems Inc, Abbott Diagnostics, Boston University, and Eurobio Scientific SA among others.

206 Ortho, Inc.: 20/20 GeneSystems Inc (20/20 Gene) carries out the discovery, development and commercialization of clinical laboratory tests. The company offers products such as BioCheck suspicious powder test kit, corona check test kit and OneTest kit. It also conducts clinical lab tests in therapeutic areas such as early detection of various types of cancers, COVID-19 antibody testing, personalized medicine, and biological detection.

Abbott Diagnostics: Abbott Diagnostics (Abbott) a subsidiary of Abbott Laboratories, is a manufacturer of in vitro diagnostic systems and tests. The company offers various core laboratory products, molecular point of care products, transfusion medicine, professional services and diagnostics.

Leading Therapeutic Drug Monitoring Companies, 2023

Leading Therapeutic Drug Monitoring Companies, 2023

For more company insights into the therapeutic drug monitoring pipeline market, download a free report sample

Segments Covered in the Report

Therapeutic Drug Monitoring Pipeline Market Segments Outlook

  • Immunosuppressant Therapeutic Drug Monitoring
  • Central Nervous Systems Therapeutic Drug Monitoring
  • Antibiotic/Antivirus Therapeutic Drug Monitoring
  • Cardiovascular Therapeutic Drug Monitoring

Therapeutic Drug Monitoring Pipeline Market Territories Outlook

  • United States
  • Europe
  • India
  • United Kingdom
  • Others

Therapeutic Drug Monitoring Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • CE-IVD
  • ICAC
  • MDITAC
  • Others

Scope

This report provides:

  • Extensive coverage of the Therapeutic drug monitoring under development.
  • Details of major pipeline products which includes product description, licensing and collaboration details, and other developmental activities.
  • Reviews of the major players involved in the development of Therapeutic drug monitoring and lists of all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage.
  • Key clinical trial data of ongoing trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of Therapeutic drug monitoring under development.
  • Develop market-entry and market expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

20/20 GeneSystems Inc
Abbott Diagnostics
Adaptive Biotechnologies Corp
Affinergy LLC
Animated Dynamics Inc
Applied Research using OMIC Sciences SL
ARK Diagnostics Inc
AutoGenomics Inc
Avacta Group Plc
BG Medicine Inc
BIOHOPE Scientific SL
Boston University
CCC Diagnostics LLC
Centre Hospitalier Universitaire de Nice
Chronix Biomedical Inc
Cognizance Biomarkers LLC
Columbia University
ContraVac Inc (Inactive)
Denovo Biolabs Pvt Ltd
DNAPrint Genomics Inc (Inactive)
Dublin City University
Ecole Polytechnique Federale de Lausanne
ELITechGroup Inc
Eurobio Scientific SA
Gene Express, Inc. (Inactive)
GenMark Diagnostics Inc
Horiba Ltd
Inflammatix Inc
Instrumentation Laboratory Co
Johns Hopkins University
KIYATEC Inc
Medibio Ltd
Medical Research Council
Metabolon Inc
Newcastle University
Nipro Europe N.V.
Nuclea Biotechnologies Inc. (Inactive)
PanGenomic Health Inc
Pax Neuroscience Inc
Pelago Bioscience AB
Pennsylvania State University
Plateletdiagnostics LLC
Prediction Sciences LLC (Inactive)
ProciseDx LLC
Progenika Biopharma SA
PrognosDx Health Inc
Prometheus Laboratories Inc
Proteomika (Inactive)
Purdue University
Queen Mary University of London
Roche Diagnostics Corp
Roche Diagnostics International Ltd
Rockland Immunochemicals Inc
SAGA Diagnostics AB
Saladax Biomedical Inc
Siemens Healthcare Diagnostics Inc
Sirius Genomics Inc
Spanish National Research Council
SQI Diagnostics Inc
T2 Biosystems Inc
Thermo Fisher Scientific Inc
Universidade Feevale
University of Colorado
University of Colorado Denver
University of North Dakota
University of Queensland
University of Washington
Vyant Bio Inc

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 8

|1.2 List of Figures 16

2 Introduction 17

2.1 Therapeutic Drug Monitoring Overview 17

3 Products under Development 18

3.1 Therapeutic Drug Monitoring – Pipeline Products by Stage of Development 18

3.2 Therapeutic Drug Monitoring – Pipeline Products by Segment 19

3.3 Therapeutic Drug Monitoring – Pipeline Products by Territory 20

3.4 Therapeutic Drug Monitoring – Pipeline Products by Regulatory Path 21

3.5 Therapeutic Drug Monitoring – Pipeline Products by Estimated Approval Date 22

3.6 Therapeutic Drug Monitoring – Ongoing Clinical Trials 23

4 Therapeutic Drug Monitoring – Pipeline Products under Development by Companies 24

4.1 Therapeutic Drug Monitoring Companies – Pipeline Products by Stage of Development 24

4.2 Therapeutic Drug Monitoring – Pipeline Products by Stage of Development 27

5 Therapeutic Drug Monitoring Companies and Product Overview 32

5.1 20/20 GeneSystems Inc Company Overview 32

5.1.1 20/20 GeneSystems Inc Pipeline Products & Ongoing Clinical Trials Overview 32

5.2 Abbott Diagnostics Company Overview 33

5.2.1 Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 33

5.3 Adaptive Biotechnologies Corp Company Overview 34

5.3.1 Adaptive Biotechnologies Corp Pipeline Products & Ongoing Clinical Trials Overview 34

5.4 Affinergy LLC Company Overview 35

5.4.1 Affinergy LLC Pipeline Products & Ongoing Clinical Trials Overview 35

5.5 Animated Dynamics Inc Company Overview 37

5.5.1 Animated Dynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 37

5.6 Applied Research using OMIC Sciences SL Company Overview 40

5.6.1 Applied Research using OMIC Sciences SL Pipeline Products & Ongoing Clinical Trials Overview 40

5.7 ARK Diagnostics Inc Company Overview 41

5.7.1 ARK Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 41

5.8 AutoGenomics Inc Company Overview 54

5.8.1 AutoGenomics Inc Pipeline Products & Ongoing Clinical Trials Overview 54

5.9 Avacta Group Plc Company Overview 55

5.9.1 Avacta Group Plc Pipeline Products & Ongoing Clinical Trials Overview 55

5.10 BG Medicine Inc Company Overview 59

5.10.1 BG Medicine Inc Pipeline Products & Ongoing Clinical Trials Overview 59

5.11 BIOHOPE Scientific SL Company Overview 62

5.11.1 BIOHOPE Scientific SL Pipeline Products & Ongoing Clinical Trials Overview 62

5.12 Boston University Company Overview 65

5.12.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview 65

5.13 CCC Diagnostics LLC Company Overview 66

5.13.1 CCC Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 66

5.14 Centre Hospitalier Universitaire de Nice Company Overview 67

5.14.1 Centre Hospitalier Universitaire de Nice Pipeline Products & Ongoing Clinical Trials Overview 67

5.15 Chronix Biomedical Inc Company Overview 68

5.15.1 Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 68

5.16 Cognizance Biomarkers LLC Company Overview 69

5.16.1 Cognizance Biomarkers LLC Pipeline Products & Ongoing Clinical Trials Overview 69

5.17 Columbia University Company Overview 70

5.17.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 70

5.18 ContraVac Inc (Inactive) Company Overview 71

5.18.1 ContraVac Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 71

5.19 Denovo Biolabs Pvt Ltd Company Overview 72

5.19.1 Denovo Biolabs Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 72

5.20 DNAPrint Genomics Inc (Inactive) Company Overview 73

5.20.1 DNAPrint Genomics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 73

5.21 Dublin City University Company Overview 76

5.21.1 Dublin City University Pipeline Products & Ongoing Clinical Trials Overview 76

5.22 Ecole Polytechnique Federale de Lausanne Company Overview 77

5.22.1 Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview 77

5.23 ELITechGroup Inc Company Overview 78

5.23.1 ELITechGroup Inc Pipeline Products & Ongoing Clinical Trials Overview 78

5.24 Eurobio Scientific SA Company Overview 83

5.24.1 Eurobio Scientific SA Pipeline Products & Ongoing Clinical Trials Overview 83

5.25 Gene Express, Inc. (Inactive) Company Overview 84

5.25.1 Gene Express, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 84

5.26 GenMark Diagnostics Inc Company Overview 86

5.26.1 GenMark Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 86

5.27 Horiba Ltd Company Overview 88

5.27.1 Horiba Ltd Pipeline Products & Ongoing Clinical Trials Overview 88

5.28 Inflammatix Inc Company Overview 90

5.28.1 Inflammatix Inc Pipeline Products & Ongoing Clinical Trials Overview 90

5.29 Instrumentation Laboratory Co Company Overview 91

5.29.1 Instrumentation Laboratory Co Pipeline Products & Ongoing Clinical Trials Overview 91

5.30 Johns Hopkins University Company Overview 92

5.30.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 92

5.31 KIYATEC Inc Company Overview 93

5.31.1 KIYATEC Inc Pipeline Products & Ongoing Clinical Trials Overview 93

5.32 Medibio Ltd Company Overview 96

5.32.1 Medibio Ltd Pipeline Products & Ongoing Clinical Trials Overview 96

5.33 Medical Research Council Company Overview 99

5.33.1 Medical Research Council Pipeline Products & Ongoing Clinical Trials Overview 99

5.34 Metabolon Inc Company Overview 100

5.34.1 Metabolon Inc Pipeline Products & Ongoing Clinical Trials Overview 100

5.35 Newcastle University Company Overview 102

5.35.1 Newcastle University Pipeline Products & Ongoing Clinical Trials Overview 102

5.36 Nipro Europe N.V. Company Overview 103

5.36.1 Nipro Europe N.V. Pipeline Products & Ongoing Clinical Trials Overview 103

5.37 Nuclea Biotechnologies Inc. (Inactive) Company Overview 104

5.37.1 Nuclea Biotechnologies Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 104

5.38 PanGenomic Health Inc Company Overview 106

5.38.1 PanGenomic Health Inc Pipeline Products & Ongoing Clinical Trials Overview 106

5.39 Pax Neuroscience Inc Company Overview 107

5.39.1 Pax Neuroscience Inc Pipeline Products & Ongoing Clinical Trials Overview 107

5.40 Pelago Bioscience AB Company Overview 108

5.40.1 Pelago Bioscience AB Pipeline Products & Ongoing Clinical Trials Overview 108

5.41 Pennsylvania State University Company Overview 109

5.41.1 Pennsylvania State University Pipeline Products & Ongoing Clinical Trials Overview 109

5.42 Plateletdiagnostics LLC Company Overview 110

5.42.1 Plateletdiagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 110

5.43 Prediction Sciences LLC (Inactive) Company Overview 111

5.43.1 Prediction Sciences LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 111

5.44 ProciseDx LLC Company Overview 113

5.44.1 ProciseDx LLC Pipeline Products & Ongoing Clinical Trials Overview 113

5.45 Progenika Biopharma SA Company Overview 115

5.45.1 Progenika Biopharma SA Pipeline Products & Ongoing Clinical Trials Overview 115

5.46 PrognosDx Health Inc Company Overview 116

5.46.1 PrognosDx Health Inc Pipeline Products & Ongoing Clinical Trials Overview 116

5.47 Prometheus Laboratories Inc Company Overview 118

5.47.1 Prometheus Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 118

5.48 Proteomika (Inactive) Company Overview 124

5.48.1 Proteomika (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 124

5.49 Purdue University Company Overview 127

5.49.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview 127

5.50 Queen Mary University of London Company Overview 128

5.50.1 Queen Mary University of London Pipeline Products & Ongoing Clinical Trials Overview 128

5.51 Roche Diagnostics Corp Company Overview 129

5.51.1 Roche Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview 129

5.52 Roche Diagnostics International Ltd Company Overview 130

5.52.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 130

5.53 Rockland Immunochemicals Inc Company Overview 150

5.53.1 Rockland Immunochemicals Inc Pipeline Products & Ongoing Clinical Trials Overview 150

5.54 SAGA Diagnostics AB Company Overview 151

5.54.1 SAGA Diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview 151

5.55 Saladax Biomedical Inc Company Overview 153

5.55.1 Saladax Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 153

5.56 Siemens Healthcare Diagnostics Inc Company Overview 164

5.56.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 164

5.57 Sirius Genomics Inc Company Overview 169

5.57.1 Sirius Genomics Inc Pipeline Products & Ongoing Clinical Trials Overview 169

5.58 Spanish National Research Council Company Overview 170

5.58.1 Spanish National Research Council Pipeline Products & Ongoing Clinical Trials Overview 170

5.59 SQI Diagnostics Inc Company Overview 171

5.59.1 SQI Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 171

5.60 T2 Biosystems Inc Company Overview 173

5.60.1 T2 Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 173

5.61 Thermo Fisher Scientific Inc Company Overview 174

5.61.1 Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 174

5.62 Universidade Feevale Company Overview 176

5.62.1 Universidade Feevale Pipeline Products & Ongoing Clinical Trials Overview 176

5.63 University of Colorado Company Overview 177

5.63.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 177

5.64 University of Colorado Denver Company Overview 179

5.64.1 University of Colorado Denver Pipeline Products & Ongoing Clinical Trials Overview 179

5.65 University of North Dakota Company Overview 180

5.65.1 University of North Dakota Pipeline Products & Ongoing Clinical Trials Overview 180

5.66 University of Queensland Company Overview 181

5.66.1 University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 181

5.67 University of Washington Company Overview 182

5.67.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview 182

5.68 Vyant Bio Inc Company Overview 183

5.68.1 Vyant Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 183

6 Therapeutic Drug Monitoring- Recent Developments 184

6.1 Jul 17, 2023: Theradiag Reports Revenue of €6.7 Million for the First Half of 2023, up

6.8% 184

6.2 Jul 12, 2023: T2 Biosystems Announces Preliminary Second Quarter 2023 Financial Results 184

6.3 Jul 12, 2023: Revvity to Hold Earnings Call on Tuesday, August 1, 2023 185

6.4 Jul 05, 2023: Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 26, 2023 186

6.5 Jul 05, 2023: Waters Corp. Schedules Second Quarter 2023 Earnings Conference Call 186

6.6 Jun 12, 2023: Abbott Names Philip Boudreau CFO effective Sept. 1 186

6.7 Jun 02, 2023: Avacta Group Posting of Annual Report and Notice of AGM 186

6.8 May 30, 2023: SQI Diagnostics reports second quarter 2023 results 187

6.9 May 16, 2023: Genflow Biosciences Notice of Annual General Meeting 188

6.10 May 15, 2023: T2 Biosystems postpones reporting of first quarter 2023 financial results 188

6.11 May 12, 2023: Acurx Pharmaceuticals reports first quarter 2023 results and provides business update 188

6.12 May 12, 2023: Olympus announces consolidated financial results for the fiscal year ended March 31, 2023 190

6.13 May 12, 2023: Horiba announces summary of consolidated financial statements for the three months ended March 31, 2023 190

6.14 May 11, 2023: Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2023 190

6.15 May 11, 2023: Nusano announces in-house stable isotope program led by renowned physicist Sarko Cherekdjian 192

6.16 May 09, 2023: Natera reports first quarter 2023 financial results 193

6.17 May 05, 2023: Acurx Pharmaceuticals to discuss first quarter 2023 financial results and provide business update 196

6.18 May 04, 2023: Nusano to Host Key Opinion Leader Webinar on Isotope Production and Applications for Oncology Radiopharmaceuticals 196

6.19 May 03, 2023: Adaptive Biotechnologies reports First Quarter 2023 financial results 197

6.20 Apr 17, 2023: Nusano announces Q1 2025 opening date for medical radioisotope production facility in Utah 198

6.21 Apr 05, 2023: Eurobio Scientific Announces 2022 Annual Results 198

6.22 Apr 03, 2023: Avacta Group Announces Notice of Financial Results for 31 December 2022 200

6.23 Mar 31, 2023: HealthBeacon Announces 2022 Preliminary Results 200

6.24 Mar 22, 2023: DiagnaMed Announces Dr. Bassma Ghali as Vice President of Product 201

6.25 Mar 16, 2023: Acurx Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update 202

6.26 Mar 16, 2023: Incannex to Commercialise its Psychedelic Clinics Business in Collaborative Partnership with Leading Psychedelic Experts 204

6.27 Mar 15, 2023: Clario Announces Global Clinical Research Expert, Rod MacKenzie CMG, PH.D., New Chairman of the Board of Directors 206

6.28 Mar 13, 2023: T2 Biosystems Announces Fourth Quarter and Full Year 2022 Financial Results 206

6.29 Mar 09, 2023: Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2022 207

6.30 Mar 09, 2023: PerkinElmer to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum 209

6.31 Feb 24, 2023: Diagnostix elects Ger van Jeveren to its board of directors ahead of IPO 209

6.32 Feb 23, 2023: Natera Appoints Ruth E. Williams-Brinkley to its Board of Directors 209

6.33 Feb 21, 2023: Halberd demonstrates simultaneous eradication of multiple strains of CDC provided antibiotic resistant bacteria 210

6.34 Feb 15, 2023: Mahana Therapeutics Appoints Justin Zamirowski, Jr. as Chief Commercial Officer 210

6.35 Feb 14, 2023: Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2022 Financial Results 211

6.36 Feb 14, 2023: Horiba Announces Summary of Consolidated Financial Statements for the Year Ended December 31, 2022 212

6.37 Feb 13, 2023: DiagnaMed Announces Appointment of New Director 214

6.38 Feb 10, 2023: Olympus Announces Consolidated Financial Results for the Third Quarter and Full-year Forecasts for Fiscal 2023 214

6.39 Feb 09, 2023: SenzaGen Invitation to the presentation of year-end report 2022 on Feb 16 at

14.00 CET 214

6.40 Feb 09, 2023: Oxford scientists develop test that can identify respiratory viruses within five minutes 215

6.41 Feb 08, 2023: Eurobio Scientific formalises the appointment of Anne-Sophie Herelle as Group CFO 215

6.42 Feb 07, 2023: Unchained Labs goes viral again with new adenovirus quant application on stunner 216

6.43 Feb 07, 2023: BioMark receives funding, support, research and development project for cancer treatment monitoring 216

6.44 Feb 01, 2023: Cairn Homes Announces Ms. Orla O’Gorman step down as Non-Executive Director of HealthBeacon 217

6.45 Jan 23, 2023: Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2022 Financial Results on February 14, 2023 217

6.46 Jan 23, 2023: T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2022 Financial Results 217

6.47 Jan 20, 2023: Quest Diagnostics to Release Fourth Quarter and Full Year 2022 Financial Results on February 2, 2023 218

6.48 Jan 20, 2023: Joint statement by Executive Steering Group on shortages and safety of medicinal products (MSSG) on shortages of antibiotic medicines 218

6.49 Jan 18, 2023: Waters Corporation Schedules Fourth Quarter 2022 Earnings Conference Call 219

6.50 Jan 16, 2023: TheraDiag Reports 2022 Revenue of €12.2 Million, up

9.7% 219

6.51 Jan 08, 2023: Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2023 221

6.52 Dec 23, 2022: Asep Medical achieves significant milestones addressing antibiotic failure through proprietary diagnostic & therapeutic technologies 222

6.53 Dec 20, 2022: New blood test to identify infections could reduce global antibiotic overuse 223

6.54 Dec 16, 2022: HealthBeacon appoints Lar Malone as interim chief financial officer 224

6.55 Dec 15, 2022: Bristol Myers Squibb to Report Results for Fourth Quarter 2022 on February 2, 2023 224

6.56 Nov 21, 2022: Thermo Fisher Scientific to Present at Evercore ISI HealthCONx Conference 225

6.57 Nov 11, 2022: Olympus Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2023 225

6.58 Nov 11, 2022: Horiba Announces Summary of Consolidated Financial Statements for the Nine Months Ended September 30, 2022 227

6.59 Nov 11, 2022: Olympus Announces Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2023 227

6.60 Nov 09, 2022: Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2022 227

6.61 Nov 08, 2022: PerkinElmer Announces Financial Results for the Third Quarter of 2022 229

6.62 Nov 03, 2022: Adaptive Biotechnologies Reports Third Quarter 2022 Financial Results 231

6.63 Nov 01, 2022: Waters Corp Reports Third Quarter 2022 Financial Results 232

6.64 Oct 24, 2022: Cohere Health and Humana Expand Partnership to Further Improve Physician and Member Experiences 233

6.65 Oct 21, 2022: Olympus Announces Leadership Succession Plan 234

6.66 Oct 21, 2022: Olympus Corp Notice Concerning Changes of Representative Executive Officer and Management Team 234

6.67 Oct 13, 2022: Biomerica Reports 30% Increase in Revenues for Fiscal Q1 2023 vs. Fiscal Q1 2022 235

6.68 Oct 12, 2022: T2 Biosystems Announces Preliminary Third Quarter 2022 Financial Results and Updates 2022 Financial Outlook 235

6.69 Oct 10, 2022: Creso Pharma accelerates company strategy with two new Director appointments, board transition and rebranding strategy to unlock additional M&A opportunities 237

6.70 Sep 30, 2022: Theradiag: Appointment of an Independent Expert 237

6.71 Sep 29, 2022: Avacta Group Announces Interim Results for the Period Ended 30 June 2022 238

6.72 Sep 19, 2022: Theradiag Announces Its Results for the First Half of 2022: Breaking-Even and Confirming Its Ability to Be Structurally Profitable From Early 2023 240

6.73 Sep 14, 2022: Horiba announces Review of First Half of 2022 241

6.74 Sep 08, 2022: Quest Diagnostics to Speak at the Morgan Stanley 20th Annual Global Healthcare Conference 241

6.75 Sep 07, 2022: Amneal Appoints Gustavo Pesquin as Executive Vice President Chief Commercial Officer 242

6.76 Aug 31, 2022: Bristol Myers Squibb to Participate in Citi’s 17th Annual BioPharma Conference 242

6.77 Aug 30, 2022: Biomerica Plans Launch of InFoods IBS Test; Names Robert Carlson as Chief Commercial Officer 242

6.78 Aug 29, 2022: SQI Diagnostics Reports Third Quarter 2022 Results 243

6.79 Aug 24, 2022: New line of electrochemistry bench meters simplify pH, conductivity and dissolved oxygen measurement 244

6.80 Aug 15, 2022: Acurx Pharmaceuticals Reports Second Quarter 2022 Results 245

6.81 Aug 12, 2022: Horiba announce Summary of Consolidated Financial Statements for the Six Months Ended June 30, 2022 246

6.82 Aug 11, 2022: Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter Ended June 30, 2022 247

6.83 Aug 11, 2022: Precipio Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 248

6.84 Aug 10, 2022: Olympus announces First Quarter Results 248

6.85 Aug 09, 2022: Olympus Corp. Announces Consolidated Financial Results for the Three Months of the Fiscal Year Ending March 31, 2023 249

6.86 Aug 08, 2022: Precipio Announces Second Quarter Shareholder Update Call 250

6.87 Aug 04, 2022: Aurinia Reports Second Quarter and Six Months 2022 Financial and Operational Results 251

6.88 Aug 03, 2022: Adaptive Biotechnologies Reports Second Quarter 2022 Financial Results 253

6.89 Aug 01, 2022: PerkinElmer Announces Financial Results for the Second Quarter of 2022 254

7 Appendix 256

7.1 Methodology 256

7.2 About GlobalData 259

7.3 Contact Us 259

7.4 Disclaimer 259

Table

Therapeutic Drug Monitoring – Pipeline Products by Stage of Development 18

Therapeutic Drug Monitoring – Pipeline Products by Segment 19

Therapeutic Drug Monitoring – Pipeline Products by Territory 20

Therapeutic Drug Monitoring – Pipeline Products by Regulatory Path 21

Therapeutic Drug Monitoring – Pipeline Products by Estimated Approval Date 22

Therapeutic Drug Monitoring – Ongoing Clinical Trials 23

Therapeutic Drug Monitoring Companies – Pipeline Products by Stage of Development 24

Therapeutic Drug Monitoring – Pipeline Products by Stage of Development 27

20/20 GeneSystems Inc Pipeline Products & Ongoing Clinical Trials Overview 32

PredicTOR Breast Test – Product Status 32

PredicTOR Breast Test – Product Description 32

Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 33

Methotrexate Chemiluminescent Assay – Product Status 33

Methotrexate Chemiluminescent Assay – Product Description 33

Adaptive Biotechnologies Corp Pipeline Products & Ongoing Clinical Trials Overview 34

Immune System Profiling – Measure Of Vaccine Efficacy – Product Status 34

Immune System Profiling – Measure Of Vaccine Efficacy – Product Description 34

Affinergy LLC Pipeline Products & Ongoing Clinical Trials Overview 35

Locking Assay – Posaconazole – Product Status 35

Locking Assay – Posaconazole – Product Description 35

Phage-Based Assay – Product Status 36

Phage-Based Assay – Product Description 36

Animated Dynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 37

ONCO4D Assay – Product Status 37

ONCO4D Assay – Product Description 37

Animated Dynamics Inc – Ongoing Clinical Trials Overview 38

ONCO4D Assay – Feasibility Study of Motility Contrast Tomography for Predicting Therapeutic Response 39

ONCO4D Assay – Measuring the Impact of Onco4D Guidance 39

Applied Research using OMIC Sciences SL Pipeline Products & Ongoing Clinical Trials Overview 40

SNP-Test – Product Status 40

SNP-Test – Product Description 40

ARK Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 41

ARK Apixaban Assay – Product Status 41

ARK Apixaban Assay – Product Description 42

ARK Atazanavir Assay – Product Status 42

ARK Atazanavir Assay – Product Description 42

ARK Dabigatran Assay – Product Status 43

ARK Dabigatran Assay – Product Description 43

ARK Darunavir Assay – Product Status 43

ARK Darunavir Assay – Product Description 44

ARK Dolutegravir Assay – Product Status 44

ARK Dolutegravir Assay – Product Description 44

ARK Edoxaban Assay – Product Status 45

ARK Edoxaban Assay – Product Description 45

ARK High Sensitivity Opiates Assay – Product Status 45

ARK High Sensitivity Opiates Assay – Product Description 46

ARK Indinavir Assay – Product Status 46

ARK Indinavir Assay – Product Description 46

ARK Lopinavir Assay – Product Status 47

ARK Lopinavir Assay – Product Description 47

ARK Maraviroc Assay – Product Status 47

ARK Maraviroc Assay – Product Description 48

ARK Nelfinavir Assay – Product Status 48

ARK Nelfinavir Assay – Product Description 48

ARK Nevirapine Assay – Product Status 49

ARK Nevirapine Assay – Product Description 49

ARK Perampanel Assay – Product Status 49

ARK Perampanel Assay – Product Description 50

ARK Rivaroxaban Assay – Product Status 50

ARK Rivaroxaban Assay – Product Description 50

ARK Saquinavir Assay – Product Status 51

ARK Saquinavir Assay – Product Description 51

ARK Tiagabine Assay – Product Status 51

ARK Tiagabine Assay – Product Description 52

ARK Zolpidem Assay – Product Status 52

ARK Zolpidem Assay – Product Description 52

ARK Zopiclone Assay – Product Status 53

ARK Zopiclone Assay – Product Description 53

AutoGenomics Inc Pipeline Products & Ongoing Clinical Trials Overview 54

Plavix Panel Test – Product Status 54

Plavix Panel Test – Product Description 54

Avacta Group Plc Pipeline Products & Ongoing Clinical Trials Overview 55

Depression Test – Product Status 55

Depression Test – Product Description 55

Diagnostic Assay – Alzheimer’s Disease – Product Status 56

Diagnostic Assay – Alzheimer’s Disease – Product Description 56

Diagnostic Test – ADHD – Product Status 56

Diagnostic Test – ADHD – Product Description 57

Diagnostic Test – Bipolar Disorder – Product Status 57

Diagnostic Test – Bipolar Disorder – Product Description 57

Schizophrenia Response Test – Product Status 57

Schizophrenia Response Test – Product Description 58

Schizophrenia Side Effects Test – Product Status 58

Schizophrenia Side Effects Test – Product Description 58

BG Medicine Inc Pipeline Products & Ongoing Clinical Trials Overview 59

Avandia Response – Product Status 59

Avandia Response – Product Description 59

Biomarker Test – Enbrel – Product Status 60

Biomarker Test – Enbrel – Product Description 60

Biomarker Test – Humira – Product Status 60

Biomarker Test – Humira – Product Description 60

Biomarker Test – Remicade – Product Status 61

Biomarker Test – Remicade – Product Description 61

BIOHOPE Scientific SL Pipeline Products & Ongoing Clinical Trials Overview 62

Immunobiogram – Renal Transplantation – Product Status 62

Immunobiogram – Renal Transplantation – Product Description 62

BIOHOPE Scientific SL – Ongoing Clinical Trials Overview 63

Immunobiogram – Renal Transplantation – Longitudinal Observational Study to Determine the Correlation Between Patient’s Pharmacodynamic Response to Immunosuppressants Measured in Vitro with IMMUNOBIOGRAM and of Rejection in Graft Biopsies in Patients with Renal Transplantation 64

Boston University Pipeline Products & Ongoing Clinical Trials Overview 65

ELISA Assay – Tenofovir – Product Status 65

ELISA Assay – Tenofovir – Product Description 65

CCC Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 66

DirectHit Drug Response Indicator Test Panel – Gastrointestinal Cancer – Product Status 66

DirectHit Drug Response Indicator Test Panel – Gastrointestinal Cancer – Product Description 66

Centre Hospitalier Universitaire de Nice Pipeline Products & Ongoing Clinical Trials Overview 67

Azacitidine Resistance Assay – Product Status 67

Azacitidine Resistance Assay – Product Description 67

Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 68

Therapeutic Monitoring Test – Pancreatic Cancer – Product Status 68

Therapeutic Monitoring Test – Pancreatic Cancer – Product Description 68

Cognizance Biomarkers LLC Pipeline Products & Ongoing Clinical Trials Overview 69

Blood Assay – mTOR Signaling – Product Status 69

Blood Assay – mTOR Signaling – Product Description 69

Columbia University Pipeline Products & Ongoing Clinical Trials Overview 70

Diagnostic Assay – Acetylcholinesterase (AChE) Activity – Product Status 70

Diagnostic Assay – Acetylcholinesterase (AChE) Activity – Product Description 70

ContraVac Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 71

SpermCheck – Contraception – Product Status 71

SpermCheck – Contraception – Product Description 71

Denovo Biolabs Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 72

DeQuanto Trastuzumab (Herceptin) PK ELISA KIT – Product Status 72

DeQuanto Trastuzumab (Herceptin) PK ELISA KIT – Product Description 72

DNAPrint Genomics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 73

Acenome – Product Status 73

Acenome – Product Description 73

Melphalan/Topotecan Response Test – Product Status 74

Melphalan/Topotecan Response Test – Product Description 74

Statinome – Product Status 74

Statinome – Product Description 75

Dublin City University Pipeline Products & Ongoing Clinical Trials Overview 76

Biomarker Based Test – Multiple Myeloma – Product Status 76

Biomarker Based Test – Multiple Myeloma – Product Description 76

Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview 77

Portable Biosensor – Product Status 77

Portable Biosensor – Product Description 77

ELITechGroup Inc Pipeline Products & Ongoing Clinical Trials Overview 78

Eon 300 Automated Chemistry Analyzer – TxB Cardio Assay – Product Status 78

Eon 300 Automated Chemistry Analyzer – TxB Cardio Assay – Product Description 78

Eon Digoxin Assay – Product Status 79

Eon Digoxin Assay – Product Description 79

Eon Theophylline Assay – Product Status 79

Eon Theophylline Assay – Product Description 79

Phenobarbital Assay – Product Status 80

Phenobarbital Assay – Product Description 80

Phenytoin Assay – Product Status 80

Phenytoin Assay – Product Description 80

Selectra ProM Chemistry System – TxB Cardio Assay – Product Status 81

Selectra ProM Chemistry System – TxB Cardio Assay – Product Description 81

Selectra ProS Chemistry System – TxB Cardio Assay – Product Status 81

Selectra ProS Chemistry System – TxB Cardio Assay – Product Description 82

Eurobio Scientific SA Pipeline Products & Ongoing Clinical Trials Overview 83

Therapeutic Drug Monitoring Test – Resistant Cancer – Product Status 83

Therapeutic Drug Monitoring Test – Resistant Cancer – Product Description 83

Gene Express, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 84

Cisplatin Chemoresistance Test – Product Status 84

Cisplatin Chemoresistance Test – Product Description 84

Prognostic Test – Irinotecan Chemoresistance – Product Status 85

Prognostic Test – Irinotecan Chemoresistance – Product Description 85

GenMark Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 86

2D6 Tamoxifen Metabolism Test – Product Status 86

2D6 Tamoxifen Metabolism Test – Product Description 86

eSensor 2C19 Genotyping Test – Product Status 87

eSensor 2C19 Genotyping Test – Product Description 87

Horiba Ltd Pipeline Products & Ongoing Clinical Trials Overview 88

ABX Pentra 400 Analyzer – TDM Assay – Product Status 88

ABX Pentra 400 Analyzer – TDM Assay – Product Description 88

Pentra C200 Analyzer – TDM Assay – Product Status 89

Pentra C200 Analyzer – TDM Assay – Product Description 89

Inflammatix Inc Pipeline Products & Ongoing Clinical Trials Overview 90

HostDxTNFresponse – Product Status 90

HostDxTNFresponse – Product Description 90

Instrumentation Laboratory Co Pipeline Products & Ongoing Clinical Trials Overview 91

HemosIL Dabigatran Assay – Product Status 91

HemosIL Dabigatran Assay – Product Description 91

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 92

Predictive Test For Chemotherapy Regimen – Product Status 92

Predictive Test For Chemotherapy Regimen – Product Description 92

KIYATEC Inc Pipeline Products & Ongoing Clinical Trials Overview 93

Ex Vivo 3D Drug Response (EV3D) Assay – Product Status 93

Ex Vivo 3D Drug Response (EV3D) Assay – Product Description 93

KIYATEC Inc – Ongoing Clinical Trials Overview 94

Ex Vivo 3D Drug Response (EV3D) Assay – 3D Prediction of Patient-specific Response Using Ex Vivo Interrogation of Live Cells from Tumors: 3D-PREDICT REGISTRY 95

Medibio Ltd Pipeline Products & Ongoing Clinical Trials Overview 96

Medibio RX – Bipolar – Product Status 96

Medibio RX – Bipolar – Product Description 96

Medibio RX – General Anxiety Disorders – Product Status 97

Medibio RX – General Anxiety Disorders – Product Description 97

Medibio RX – PTSD – Product Status 97

Medibio RX – PTSD – Product Description 97

Medibio RX – Schizophrenia – Product Status 98

Medibio RX – Schizophrenia – Product Description 98

Medical Research Council Pipeline Products & Ongoing Clinical Trials Overview 99

Diagnostic Assay – Hormone Dependent Tumours – Product Status 99

Diagnostic Assay – Hormone Dependent Tumours – Product Description 99

Metabolon Inc Pipeline Products & Ongoing Clinical Trials Overview 100

Cisplatin Tolerance Test – Product Status 100

Cisplatin Tolerance Test – Product Description 100

Prostate Cancer TDM Test – Product Status 101

Prostate Cancer TDM Test – Product Description 101

Newcastle University Pipeline Products & Ongoing Clinical Trials Overview 102

Thiopurines Assay – Product Status 102

Thiopurines Assay – Product Description 102

Nipro Europe N.V. Pipeline Products & Ongoing Clinical Trials Overview 103

Lithium Assay – Product Status 103

Lithium Assay – Product Description 103

Nuclea Biotechnologies Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 104

EGFR TK Sensitivity Lung Cancer Diagnostic Test – Product Status 104

EGFR TK Sensitivity Lung Cancer Diagnostic Test – Product Description 104

Irinotecan Sensitivity Diagnostic Test – Colon Cancer – Product Status 105

Irinotecan Sensitivity Diagnostic Test – Colon Cancer – Product Description 105

PanGenomic Health Inc Pipeline Products & Ongoing Clinical Trials Overview 106

Treatment Efficacy Monitoring Assay – Product Status 106

Treatment Efficacy Monitoring Assay – Product Description 106

Pax Neuroscience Inc Pipeline Products & Ongoing Clinical Trials Overview 107

MoodMark Rx – Product Status 107

MoodMark Rx – Product Description 107

Pelago Bioscience AB Pipeline Products & Ongoing Clinical Trials Overview 108

CETSA – Product Status 108

CETSA – Product Description 108

Pennsylvania State University Pipeline Products & Ongoing Clinical Trials Overview 109

Antiobody-Based ELISA Assay – ACTS – Product Status 109

Antiobody-Based ELISA Assay – ACTS – Product Description 109

Plateletdiagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 110

pDrp1 Assay – Product Status 110

pDrp1 Assay – Product Description 110

Prediction Sciences LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 111

GeneRx For Hypertension Treatment – Product Status 111

GeneRx For Hypertension Treatment – Product Description 111

GeneRx Lithium/Bipolar Test – Product Status 112

GeneRx Lithium/Bipolar Test – Product Description 112

ProciseDx LLC Pipeline Products & Ongoing Clinical Trials Overview 113

Procise ADL – Product Status 113

Procise ADL – Product Description 113

Procise IFX – Product Status 114

Procise IFX – Product Description 114

Progenika Biopharma SA Pipeline Products & Ongoing Clinical Trials Overview 115

Promonitor – Autoimmune And Inflammation – Product Status 115

Promonitor – Autoimmune And Inflammation – Product Description 115

PrognosDx Health Inc Pipeline Products & Ongoing Clinical Trials Overview 116

RxScore Therapeutic Response Test – Breast Cancer – Product Status 116

RxScore Therapeutic Response Test – Breast Cancer – Product Description 116

RxScore Therapeutic Response Test – Pancreatic Cancer – Product Status 117

RxScore Therapeutic Response Test – Pancreatic Cancer – Product Description 117

Prometheus Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 118

PL-200 PredictrPK – CD/UC Adalimumab – Product Status 118

PL-200 PredictrPK – CD/UC Adalimumab – Product Description 119

PL-200 PredictrPK – CD/UC Infliximab – Product Status 119

PL-200 PredictrPK – CD/UC Infliximab – Product Description 120

PL-200 PredictrPK – CD/UC Ustekinumab – Product Status 120

PL-200 PredictrPK – CD/UC Ustekinumab – Product Description 121

PL-200 PredictrPK – CD/UC Vedolizumab – Product Status 121

PL-200 PredictrPK – CD/UC Vedolizumab – Product Description 121

PL-300 Monitr – Product Status 122

PL-300 Monitr – Product Description 122

PL-400 CD/UC Infliximab/Adalimumab – Product Status 122

PL-400 CD/UC Infliximab/Adalimumab – Product Description 123

PL-600 Anser CD Risankizumab – Product Status 123

PL-600 Anser CD Risankizumab – Product Description 123

Proteomika (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 124

Promonitor-Anti-CZP (Certolizumab) – Product Status 124

Promonitor-Anti-CZP (Certolizumab) – Product Description 124

Promonitor-Anti-TCZ (Tocilizumab) – Product Status 125

Promonitor-Anti-TCZ (Tocilizumab) – Product Description 125

Promonitor-CZP (Certolizumab) – Product Status 125

Promonitor-CZP (Certolizumab) – Product Description 126

Promonitor-TCZ (Tocilizumab) – Product Status 126

Promonitor-TCZ (Tocilizumab) – Product Description 126

Purdue University Pipeline Products & Ongoing Clinical Trials Overview 127

Point-Of-Care Mass Spectrometry Analysis System – Product Status 127

Point-Of-Care Mass Spectrometry Analysis System – Product Description 127

Queen Mary University of London Pipeline Products & Ongoing Clinical Trials Overview 128

Hepatocyte – Based Drug Screen Assay – Product Status 128

Hepatocyte – Based Drug Screen Assay – Product Description 128

Roche Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview 129

Liat Assay – Pharmacogenomics – Product Status 129

Liat Assay – Pharmacogenomics – Product Description 129

Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 130

Cobas – Cyclosporin A Assay – Product Status 131

Cobas – Cyclosporin A Assay – Product Description 131

Cobas 6000 Analyzer Series With c 501 Module – Cyclosporine Assay – Product Status 132

Cobas 6000 Analyzer Series With c 501 Module – Cyclosporine Assay – Product Description 132

Cobas 6000 Analyzer Series With c 501 Module – Lidocaine Assay – Product Status 132

Cobas 6000 Analyzer Series With c 501 Module – Lidocaine Assay – Product Description 132

Cobas 6000 Analyzer Series With c 501 Module – Tacrolimus Assay – Product Status 133

Cobas 6000 Analyzer Series With c 501 Module – Tacrolimus Assay – Product Description 133

Cobas 6000 Analyzer Series With e 601 Module – Cyclosporine Assay – Product Status 133

Cobas 6000 Analyzer Series With e 601 Module – Cyclosporine Assay – Product Description 134

Cobas 6000 Analyzer Series With e 601 Module – Everolimus Assay – Product Status 134

Cobas 6000 Analyzer Series With e 601 Module – Everolimus Assay – Product Description 134

Cobas 6000 Analyzer Series With e 601 Module – Sirolimus Assay – Product Status 135

Cobas 6000 Analyzer Series With e 601 Module – Sirolimus Assay – Product Description 135

Cobas 8000 Analyzer Series With c 502 Module – Everolimus Assay – Product Status 135

Cobas 8000 Analyzer Series With c 502 Module – Everolimus Assay – Product Description 136

Cobas 8000 Analyzer Series With c 502 Module – Lidocaine Assay – Product Status 136

Cobas 8000 Analyzer Series With c 502 Module – Lidocaine Assay – Product Description 136

Cobas 8000 Analyzer Series With c 502 Module – Sirolimus Assay – Product Status 136

Cobas 8000 Analyzer Series With c 502 Module – Sirolimus Assay – Product Description 137

Cobas 8000 Analyzer Series With c 502 Module – Tacrolimus Assay – Product Status 137

Cobas 8000 Analyzer Series With c 502 Module – Tacrolimus Assay – Product Description 137

Cobas 8000 Analyzer Series With c 701 Module – Everolimus Assay – Product Status 138

Cobas 8000 Analyzer Series With c 701 Module – Everolimus Assay – Product Description 138

Cobas 8000 Analyzer Series With c 701 Module – Lidocaine Assay – Product Status 138

Cobas 8000 Analyzer Series With c 701 Module – Lidocaine Assay – Product Description 139

Cobas 8000 Analyzer Series With c 701 Module – Sirolimus Assay – Product Status 139

Cobas 8000 Analyzer Series With c 701 Module – Sirolimus Assay – Product Description 139

Cobas 8000 Analyzer Series With c 701 Module – Tacrolimus Assay – Product Status 140

Cobas 8000 Analyzer Series With c 701 Module – Tacrolimus Assay – Product Description 140

Cobas 8000 Analyzer Series With c 702 Module – Everolimus Assay – Product Status 140

Cobas 8000 Analyzer Series With c 702 Module – Everolimus Assay – Product Description 141

Cobas 8000 Analyzer Series With c 702 Module – Lidocaine Assay – Product Status 141

Cobas 8000 Analyzer Series With c 702 Module – Lidocaine Assay – Product Description 141

Cobas 8000 Analyzer Series With c 702 Module – Sirolimus Assay – Product Status 142

Cobas 8000 Analyzer Series With c 702 Module – Sirolimus Assay – Product Description 142

Cobas 8000 Analyzer Series With c 702 Module – Tacrolimus Assay – Product Status 142

Cobas 8000 Analyzer Series With c 702 Module – Tacrolimus Assay – Product Description 143

Cobas 8000 Analyzer Series With e 602 Module – Everolimus Assay – Product Status 143

Cobas 8000 Analyzer Series With e 602 Module – Everolimus Assay – Product Description 143

Cobas 8000 Analyzer Series With e 602 Module – Lidocaine Assay – Product Status 144

Cobas 8000 Analyzer Series With e 602 Module – Lidocaine Assay – Product Description 144

Cobas 8000 Analyzer Series With e 801 Module – Everolimus Assay – Product Status 144

Cobas 8000 Analyzer Series With e 801 Module – Everolimus Assay – Product Description 144

Cobas 8000 Analyzer Series With e 801 Module – Tacrolimus Assay – Product Status 145

Cobas 8000 Analyzer Series With e 801 Module – Tacrolimus Assay – Product Description 145

Cobas t 511 Coagulation Analyzer – Apixaban Assay – Product Status 145

Cobas t 511 Coagulation Analyzer – Apixaban Assay – Product Description 146

Cobas t 511 Coagulation Analyzer – Dabigatran Assay – Product Status 146

Cobas t 511 Coagulation Analyzer – Dabigatran Assay – Product Description 146

Cobas t 511 Coagulation Analyzer – Rivaroxaban Assay – Product Status 147

Cobas t 511 Coagulation Analyzer – Rivaroxaban Assay – Product Description 147

Cobas t 711 Coagulation Analyzer – Apixaban Assay – Product Status 147

Cobas t 711 Coagulation Analyzer – Apixaban Assay – Product Description 147

Cobas t 711 Coagulation Analyzer – Dabigatran Assay – Product Status 148

Cobas t 711 Coagulation Analyzer – Dabigatran Assay – Product Description 148

Cobas t 711 Coagulation Analyzer – Rivaroxaban Assay – Product Status 148

Cobas t 711 Coagulation Analyzer – Rivaroxaban Assay – Product Description 148

Integrated Modular Analytics – Tacrolimus Test – Product Status 149

Integrated Modular Analytics – Tacrolimus Test – Product Description 149

Integrated Modular Analytics System – Mycophenolic Acid Test – Product Status 149

Integrated Modular Analytics System – Mycophenolic Acid Test – Product Description 149

Rockland Immunochemicals Inc Pipeline Products & Ongoing Clinical Trials Overview 150

Akt/mTOR Signaling Pharmacodynamics Assay – Product Status 150

Akt/mTOR Signaling Pharmacodynamics Assay – Product Description 150

SAGA Diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview 151

IBSAFE – Therapy Response Monitoring & Drug Resistance – Product Status 151

IBSAFE – Therapy Response Monitoring & Drug Resistance – Product Description 151

KROMA – Therapy Response Monitoring & Drug Resistance – Product Status 152

KROMA – Therapy Response Monitoring & Drug Resistance – Product Description 152

Saladax Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 153

MyCare Assay – Busulfan – Product Status 153

MyCare Assay – Busulfan – Product Description 154

MyCare Assay – Cyclophosphamide – Product Status 154

MyCare Assay – Cyclophosphamide – Product Description 154

MyCare Assay – Doxorubicin – Product Status 154

MyCare Assay – Doxorubicin – Product Description 155

MyCare Assay – Gemcitabine – Product Status 155

MyCare Assay – Gemcitabine – Product Description 155

MyCare Assay – Irinotecan – Product Status 156

MyCare Assay – Irinotecan – Product Description 156

MyCare Assay – Lenalidomide – Product Status 156

MyCare Assay – Lenalidomide – Product Description 156

MyCare Assay – Thalidomide – Product Status 157

MyCare Assay – Thalidomide – Product Description 157

MyCare Assay – Tyrosine Kinase Inhibitor – Product Status 157

MyCare Assay – Tyrosine Kinase Inhibitor – Product Description 157

MyCare Assay – Vincristine – Product Status 158

MyCare Assay – Vincristine – Product Description 158

MyCare Psychiatry Aripiprazole Assay Kit – Product Status 158

MyCare Psychiatry Aripiprazole Assay Kit – Product Description 159

MyCare Psychiatry Olanzapine Assay Kit – Product Status 159

MyCare Psychiatry Olanzapine Assay Kit – Product Description 159

MyCare Psychiatry Quetiapine Assay Kit – Product Status 160

MyCare Psychiatry Quetiapine Assay Kit – Product Description 160

MyCare Psychiatry Total Risperidone Assay Kit – Product Status 160

MyCare Psychiatry Total Risperidone Assay Kit – Product Description 161

Nanoparticle Immunoassay Kit – TDM – Product Status 161

Nanoparticle Immunoassay Kit – TDM – Product Description 161

Saladax Biomedical Inc – Ongoing Clinical Trials Overview 162

MyCare Assay – Busulfan – Collection of Plasma Samples Using Sodium Heparin From Subjects Undergoing Intravenous Busulfan Treatment 163

Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 164

ADVIA Everolimus Assay – Product Status 164

ADVIA Everolimus Assay – Product Description 164

ADVIA Sirolimus Assay – Product Status 165

ADVIA Sirolimus Assay – Product Description 165

ADVIA Tacrolimus Assay – Product Status 165

ADVIA Tacrolimus Assay – Product Description 166

Atellica IM Analyzer – Everolimus Assay – Product Status 166

Atellica IM Analyzer – Everolimus Assay – Product Description 166

Atellica IM Analyzer – Sirolimus Assay – Product Status 167

Atellica IM Analyzer – Sirolimus Assay – Product Description 167

Atellica Solution Clinical Chemistry Analyzer – Levetiracetam – Product Status 167

Atellica Solution Clinical Chemistry Analyzer – Levetiracetam – Product Description 168

Sirius Genomics Inc Pipeline Products & Ongoing Clinical Trials Overview 169

Pharmacogenetic Test – Product Status 169

Pharmacogenetic Test – Product Description 169

Spanish National Research Council Pipeline Products & Ongoing Clinical Trials Overview 170

Blood-Based Immunoassay – Oral Anticoagulants – Product Status 170

Blood-Based Immunoassay – Oral Anticoagulants – Product Description 170

SQI Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 171

Ig_PLEX TNF Assay – Product Status 171

Ig_PLEX TNF Assay – Product Description 171

Multiplex Anti Drug Antibody Assay – Product Status 172

Multiplex Anti Drug Antibody Assay – Product Description 172

T2 Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 173

T2Endotoxin – Product Status 173

T2Endotoxin – Product Description 173

Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 174

Cascadion SM Clinical Analyzer – Therapeutic Drug Monitoring – Product Status 174

Cascadion SM Clinical Analyzer – Therapeutic Drug Monitoring – Product Description 174

Cascadion SM Immunosuppressants Panel – Product Status 175

Cascadion SM Immunosuppressants Panel – Product Description 175

Universidade Feevale Pipeline Products & Ongoing Clinical Trials Overview 176

Dried Plasma Spot Assay – Therapeutic Drug Monitoring – Product Status 176

Dried Plasma Spot Assay – Therapeutic Drug Monitoring – Product Description 176

University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 177

Biomarker Assay – Schizophrenia – Product Status 177

Biomarker Assay – Schizophrenia – Product Description 177

Pharmacokinetic Drug Monitoring Device – Product Status 178

Pharmacokinetic Drug Monitoring Device – Product Description 178

University of Colorado Denver Pipeline Products & Ongoing Clinical Trials Overview 179

Therapeutic Drug Monitoring Test – HIV – Product Status 179

Therapeutic Drug Monitoring Test – HIV – Product Description 179

University of North Dakota Pipeline Products & Ongoing Clinical Trials Overview 180

Screening Assay – Anti Viral Drug – Product Status 180

Screening Assay – Anti Viral Drug – Product Description 180

University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 181

Theranostic Assay – Squamous Cell Carcinoma – Product Status 181

Theranostic Assay – Squamous Cell Carcinoma – Product Description 181

University of Washington Pipeline Products & Ongoing Clinical Trials Overview 182

Point-Of-Care Assay – Tenofovir – Product Status 182

Point-Of-Care Assay – Tenofovir – Product Description 182

Vyant Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 183

Comprehensive Pharmacogenomics Panel Test – Product Status 183

Comprehensive Pharmacogenomics Panel Test – Product Description 183

Glossary 258

Figures

Therapeutic Drug Monitoring – Pipeline Products by Stage of Development 18

Therapeutic Drug Monitoring – Pipeline Products by Segment 19

Therapeutic Drug Monitoring – Pipeline Products by Territory 20

Therapeutic Drug Monitoring – Pipeline Products by Regulatory Path 21

Therapeutic Drug Monitoring – Pipeline Products by Estimated Approval Date 22

Therapeutic Drug Monitoring – Ongoing Clinical Trials 23

Frequently asked questions

Therapeutic Drug Monitoring Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Therapeutic Drug Monitoring Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Therapeutic Drug Monitoring Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Therapeutic Drug Monitoring Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.